Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ancor Holding AB
AB
Active
Org 5566825062
Färögatan 33, 164 51
Kista
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2005
2 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Ancor Holding AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
BK
Bo Karl Daniel Jilkén
Chief Executive Officer
Chief Executive Officer
2026
HN
Henrik Nils Gunnar Boman
Chief Auditor
Chief Auditor
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
JT
Jan Tommy Lennart Hedberg
Board of Directors
2022
EJ
Emmanuel Johannes Bengtsson
Board of Directors
2026
CM
Carina Mariana Terenius Jilkén
Chairman
2026
SG
Sten Gunnar Otto Skolling
Chairman
2025
AH
Anders Henrik Weilandt
Board of Directors
2026
PM
Per Marcus Jönsson
Board of Directors
2026
Former (3)
CV
Caroline V V Lundgren Brandberg
Board of Directors
2022 – 2026
GI
Gunilla Ingeborg O Lundmark
Board of Directors
2022 – 2026
NH
Nils Henrik Milton Rammer
Chairman
2022 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Chordate Medical Holding AB (publ)
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ancor Holding AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network